{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:51:24Z","timestamp":1792450284521,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":84,"publisher":"Springer New York","isbn-type":[{"value":"9781493995035","type":"print"},{"value":"9781493995042","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9504-2_10","type":"book-chapter","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T10:02:44Z","timestamp":1558951364000},"page":"203-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Building upon Nature\u2019s Framework: Overview of Key Strategies Toward Increasing Drug-Like Properties of Natural Product Cyclopeptides and Macrocycles"],"prefix":"10.1007","author":[{"given":"Maria-Jesus","family":"Blanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"13020","DOI":"10.1002\/anie.201401058","volume":"53","author":"TA Hill","year":"2014","unstructured":"Hill TA, Shepherd NE, Diness F, Fairlie DP (2014) Constraining cyclic peptides to mimic protein structure motifs. Angew Chem Int Ed Engl 53:13020\u201313041","journal-title":"Angew Chem Int Ed Engl"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11030-005-1314-x","volume":"9","author":"LA Wessjohann","year":"2005","unstructured":"Wessjohann LA, Ruijter E, Garcia-Rivera D, Brandt W (2005) What can a chemist learn from nature\u2019s macrocycles? A brief, conceptual view. Mol Divers 9:171\u2013186","journal-title":"Mol Divers"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cbpa.2017.04.012","volume":"38","author":"MR Naylor","year":"2017","unstructured":"Naylor MR, Bockus AT, Blanco MJ, Lokey RS (2017) Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets. Curr Opin Chem Biol 38:141\u2013147","journal-title":"Curr Opin Chem Biol"},{"key":"10_CR4","doi-asserted-by":"crossref","unstructured":"Wetzler M, Hamilton P (2018) Peptides as therapeutics. In: Koutsopoulos S (ed) Peptide applications in biomedicine, biotechnology and bioengineering. Woodhead Publishing Elsevier Ltd.","DOI":"10.1016\/B978-0-08-100736-5.00008-9"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","volume":"22","author":"N Qvit","year":"2017","unstructured":"Qvit N, Rubin SJ, Urban TJ, Mochly-Rosen D, Gross ER (2017) Peptidomimetic therapeutics: scientific approaches and opportunities. Drug Discov Today 22:454\u2013462","journal-title":"Drug Discov Today"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2174\/138527206778742669","volume":"10","author":"AB Pomilio","year":"2006","unstructured":"Pomilio AB, Battista ME, Vitale AA (2006) Naturally-occurring cyclopeptides: structures and bioactivity. Curr Org Chem 10:2075\u20132121","journal-title":"Curr Org Chem"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2174\/1568026611313070005","volume":"13","author":"AT Bockus","year":"2013","unstructured":"Bockus AT, McEwen CM, Lokey RS (2013) Form and function in cyclic peptide natural products: a pharmacokinetic perspective. Curr Top Med Chem 13:821\u2013836","journal-title":"Curr Top Med Chem"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/366324a0","volume":"366","author":"MR Ghadiri","year":"1993","unstructured":"Ghadiri MR, Granja JR, Milligan RA, McRee DE, Khazanovich N (1993) Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature 366:324\u2013327","journal-title":"Nature"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1021\/ja0372659","volume":"126","author":"K Rosenthal-Aizman","year":"2004","unstructured":"Rosenthal-Aizman K, Svensson G, Und\u00e9n A (2004) Self-assembling peptide nanotubes from enantiomeric pairs of cyclic peptides with alternating D and L amino acid residues. J Am Chem Soc 126:3372\u20133373","journal-title":"J Am Chem Soc"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbpa.2017.03.011","volume":"38","author":"Z Qian","year":"2017","unstructured":"Qian Z, Dougherty PG, Pei D (2017) Targeting intracellular protein\u2013protein interactions with cell-permeable cyclic peptides. Curr Opin Chem Biol 38:80\u201386","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"10_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-016-9537-5","volume":"23","author":"B Senthilkumar","year":"2017","unstructured":"Senthilkumar B, Rajasekaran R (2017) Analysis of the structural stability among cyclotide members through cystine knot fold that underpins its potential use as a drug scaffold. Inter J Peptide Res Therap 23(1):1","journal-title":"Inter J Peptide Res Therap"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bcp.12932","volume":"83","author":"B Molesini","year":"2017","unstructured":"Molesini B, Treggiari D, Dalbeni A, Minuz P, Pandolfini T (2017) Plant cystine-knot peptides: pharmacological perspectives. Br J Clin Pharmacol 83:63\u201370","journal-title":"Br J Clin Pharmacol"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nature03192","volume":"432","author":"CM Dobson","year":"2004","unstructured":"Dobson CM (2004) Chemical space and biology. Nature 432:824\u2013828","journal-title":"Nature"},{"key":"10_CR14","unstructured":"Borel J.F. (1982) History of cyclosporin A and its significance in immunology. In: Cyclosporin A, pp 5\u201317"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/BF01973261","volume":"6","author":"JA Borel","year":"1976","unstructured":"Borel JA, Feurer C, Gubler HU, St\u00e4helin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468\u2013475","journal-title":"Agents Actions"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/hlca.19840670220","volume":"67","author":"RM Wenger","year":"1984","unstructured":"Wenger RM (1984) Synthesis of cyclosporine. Total syntheses of \u2018cyclosporin A\u2019 and \u2018cyclosporin H\u2019, two fungal metabolites isolated from the species Tolypocladium inflatum GAMS. Helv Chim Acta 67:502\u2013525","journal-title":"Helv Chim Acta"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.1021\/jm500223x","volume":"57","author":"ZK Sweeney","year":"2014","unstructured":"Sweeney ZK, Fu J, Wiedmann B (2014) From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds. J Med Chem 57:7145\u20137159","journal-title":"J Med Chem"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1096\/fj.201600911R","volume":"31","author":"Y Bai","year":"2017","unstructured":"Bai Y, King C, Francis C, Gooch J (2017) Cyclosporin A alters expression of renal MicroRNAs: new insights into calcineurin inhibitor nephrotoxicity. FASEB J 31:757\u2013713","journal-title":"FASEB J"},{"issue":"521","key":"10_CR19","first-page":"421","volume":"7","author":"S Naicker","year":"2009","unstructured":"Naicker S, Yatscoff RW, Foster RT (2009) Deuterated cyclosporine analogs and methods of making the same. US Patent 7(521):421","journal-title":"US Patent"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.4155\/fmc.15.78","volume":"7","author":"CL Ahlbach","year":"2015","unstructured":"Ahlbach CL, Lexa KW, Bockus AT, Chen V, Crews P, Jacobson MP, Lokey RS (2015) Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products. Future Med Chem 7:2121\u20132130","journal-title":"Future Med Chem"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1021\/acs.jpcb.7b12419","volume":"122","author":"CK Wang","year":"2018","unstructured":"Wang CK, Swedberg JE, Harvey PJ, Kaas Q, Craik DJ (2018) Conformational flexibility is a determinant of permeability for cyclosporin. J Phys Chem B 122:2261\u20132276","journal-title":"J Phys Chem B"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1021\/acs.jmedchem.8b00347","volume":"61","author":"M Rossi Sebastiano","year":"2018","unstructured":"Rossi Sebastiano M, Doak BC, Backlund M, Poongavanam V, Over B, Ermondi G, Caron G, Matsson P, Kihlberg J (2018) Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the rule of 5. J Med Chem 61:4189\u20134202","journal-title":"J Med Chem"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.bmc.2017.08.031","volume":"26","author":"AF R\u00e4der","year":"2018","unstructured":"R\u00e4der AF, Reichart F, Weinm\u00fcller M, Kessler H (2018) Improving oral bioavailability of cyclic peptides by N-methylation. Bioorg Med Chem 26:2766\u20132773","journal-title":"Bioorg Med Chem"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1042\/bj0410596","volume":"41","author":"R Consden","year":"1947","unstructured":"Consden R, Gordon AH, Martin AJ, Synge RL (1947) Gramicidin S: the sequence of the amino-acid residues. Biochem J 41:596","journal-title":"Biochem J"},{"key":"10_CR25","first-page":"460","volume":"47","author":"LH Kondejewski","year":"1996","unstructured":"Kondejewski LH, Farmer SW, Wishart DS, Hancock RE, Hodges RS (1996) Gramicidin S is active against both gram-positive and gram-negative bacteria. Chem Biol Drug Des 47:460\u2013466","journal-title":"Chem Biol Drug Des"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.bbamem.2013.12.019","volume":"1838","author":"T Abraham","year":"2014","unstructured":"Abraham T, Prenner EJ, Lewis RN, Mant CT, Keller S, Hodges RS, McElhaney RN (2014) Structure\u2013activity relationships of the antimicrobial peptide gramicidin S and its analogs: aqueous solubility, self-association, conformation, antimicrobial activity and interaction with model lipid membranes. Biochim Biophys Acta 1838:1420\u20131429","journal-title":"Biochim Biophys Acta"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/jm1013693","volume":"54","author":"NA Meanwell","year":"2011","unstructured":"Meanwell NA (2011) Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem 54:2529\u20132591","journal-title":"J Med Chem"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1021\/ja051002s","volume":"127","author":"J Xiao","year":"2005","unstructured":"Xiao J, Weisblum B, Wipf P (2005) Electrostatic versus steric effects in peptidomimicry: synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres. J Am Chem Soc 127:5742\u20135743","journal-title":"J Am Chem Soc"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417\u2013433","journal-title":"Microbiol Mol Biol Rev"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/ja410385c","volume":"136","author":"DW Carney","year":"2014","unstructured":"Carney DW, Schmitz KR, Truong JV, Sauer RT, Sello JK (2014) Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity. J Am Chem Soc 136:1922\u20131929","journal-title":"J Am Chem Soc"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1021\/np500158q","volume":"77","author":"JD Goodreid","year":"2014","unstructured":"Goodreid JD, Wong K, Leung E, McCaw SE, Gray-Owen SD, Lough A, Houry WA, Batey RA (2014) Total synthesis and antibacterial testing of the A54556 cyclic acyldepsipeptides isolated from Streptomyces hawaiiensis. J Nat Prod 77:2170\u20132181","journal-title":"J Nat Prod"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1016\/j.bmc.2010.08.032","volume":"18","author":"AM Socha","year":"2010","unstructured":"Socha AM, Tan NY, LaPlante KL, Sello JK (2010) Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent. Bioorganic Med Chem 18:7193\u20137202","journal-title":"Bioorganic Med Chem"},{"issue":"2","key":"10_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/acs.jmedchem.5b01451","volume":"59","author":"Jordan D. Goodreid","year":"2016","unstructured":"Goodreid JD, Janetzko J, Santa Maria Jr JP, Wong KS, Leung E, Eger BT, Bryson S, Pai EF, Gray-Owen SD, Walker S, Houry WA. (2016) Development and characterization of potent cyclic acyldepsipeptide analogues with increased antimicrobial activity. J Med Chem 59:624\u2013646","journal-title":"Journal of Medicinal Chemistry"},{"key":"10_CR34","unstructured":"Naylor M, Ly A, Schwochert J, Desai P, Gonzalez Valcarcel IC, Barrett J, Sawada G, Blanco MJ, Lokey S (2016) Amide-\u200bto-\u200bester substitutions modify the permeability and ADME properties of natural and synthetic cyclic peptides. From abstracts of papers, 252nd ACS National Meeting & Exposition, Philadelphia, PA, United States, August 21\u201325, MEDI-344"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1039\/C7SC02622F","volume":"8","author":"P Lukat","year":"2017","unstructured":"Lukat P, Katsuyama Y, Wenzel S, Binz T, K\u00f6nig C, Blankenfeldt W, Br\u00f6nstrup M, M\u00fcller R (2017) Biosynthesis of methyl-proline containing griselimycins, natural products with anti-tuberculosis activity. Chem Sci 8:7521\u20137527","journal-title":"Chem Sci"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.aaa4690","volume":"348","author":"A Kling","year":"2015","unstructured":"Kling A, Lukat P, Almeida DV, Bauer A, Fontaine E, Sordello S, Zaburannyi N, Herrmann J, Wenzel SC, K\u00f6nig C, Ammerman NC (2015) Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 348:1106\u20131112","journal-title":"Science"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.drudis.2016.11.015","volume":"22","author":"M Dong","year":"2017","unstructured":"Dong M, Pfeiffer B, Altmann KH (2017) Recent developments in natural product-based drug discovery for tuberculosis. Drug Discov Today 22:585\u2013591","journal-title":"Drug Discov Today"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1039\/C4NP00104D","volume":"32","author":"LA Salvador-Reyes","year":"2015","unstructured":"Salvador-Reyes LA, Luesch H (2015) Biological targets and mechanisms of action of natural products from marine cyanobacteria. Nat Prod Rep 32:478\u2013503","journal-title":"Nat Prod Rep"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1021\/ja7110064","volume":"130","author":"K Taori","year":"2008","unstructured":"Taori K, Paul VJ, Luesch H (2008) Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp. J Am Chem Soc 130:1806\u20131807","journal-title":"J Am Chem Soc"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/cmdc.201700563","volume":"12","author":"G Poli","year":"2017","unstructured":"Poli G, Di Fabio R, Ferrante L, Summa V, Botta M (2017) Largazole analogues as histone deacetylase inhibitors and anticancer agents: an overview of structure\u2013activity relationships. ChemMedChem 12:1917\u20131926","journal-title":"ChemMedChem"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/acs.oprd.7b00352","volume":"22","author":"QY Chen","year":"2018","unstructured":"Chen QY, Chaturvedi PR, Luesch H (2018) Process development and scale-up total synthesis of Largazole, a potent Class I histone deacetylase inhibitor. Org Process Res Dev 22:190\u2013199","journal-title":"Org Process Res Dev"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1021\/ja205972n","volume":"133","author":"KE Cole","year":"2011","unstructured":"Cole KE, Dowling DP, Boone MA, Phillips AJ, Christianson DW (2011) Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases. J Am Chem Soc 133:12474\u201312477","journal-title":"J Am Chem Soc"},{"issue":"23","key":"10_CR43","doi-asserted-by":"publisher","first-page":"10642","DOI":"10.1021\/acs.jmedchem.6b01271","volume":"59","author":"Jehad Almaliti","year":"2016","unstructured":"Almaliti J, Al-Hamashi AA, Negmeldin AT, Hanigan CL, Perera L, Pflum MK, Casero Jr RA, Tillekeratne LV. (2016) Largazole analogues embodying radical changes in the depsipeptide ring: development of a more selective and highly potent analogue. J Med Chem 59:10642\u201310660","journal-title":"Journal of Medicinal Chemistry"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jac\/dkh546","volume":"55","author":"JN Steenbergen","year":"2005","unstructured":"Steenbergen JN, Alder J, Thorne GM, Tally FP (2005) Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 55:283\u2013288","journal-title":"J Antimicrob Chemother"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4155\/fmc.13.86","volume":"5","author":"N Bionda","year":"2013","unstructured":"Bionda N, Pitteloud JP, Cudic P (2013) Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria. Future Med Chem 5:1311\u20131330","journal-title":"Future Med Chem"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1093\/jac\/dkx299","volume":"72","author":"P Daley","year":"2017","unstructured":"Daley P, Louie T, Lutz JE, Khanna S, Stoutenburgh U, Jin M, Adedoyin A, Chesnel L, Guris D, Larson KB, Murata Y (2017) Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial. J Antimicrob Chemother 72:3462\u20133470","journal-title":"J Antimicrob Chemother"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1021\/acs.jmedchem.5b00366","volume":"58","author":"N Yin","year":"2015","unstructured":"Yin N, Li J, He Y, Herradura P, Pearson A, Mesleh MF, Mascio CT, Howland K, Steenbergen J, Thorne GM, Citron D (2015) Structure\u2013activity relationship studies of a series of semisynthetic lipopeptides leading to the discovery of Surotomycin, a novel cyclic lipopeptide being developed for the treatment of Clostridium difficile-associated diarrhea. J Med Chem 58:5137\u20135142","journal-title":"J Med Chem"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/jac\/dkw246","volume":"71","author":"CH Lee","year":"2016","unstructured":"Lee CH, Patino H, Stevens C, Rege S, Chesnel L, Louie T, Mullane KM (2016) Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial. J Antimicrob Chemother 71:2964\u20132971","journal-title":"J Antimicrob Chemother"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/np068056f","volume":"70","author":"DB Borders","year":"2007","unstructured":"Borders DB, Leese RA, Jarolmen H, Francis ND, Fantini AA, Falla T, Fiddes JC, Aumelas A (2007) Laspartomycin, an acidic lipopeptide antibiotic with a unique peptide core. J Nat Prod 70:443\u2013446","journal-title":"J Nat Prod"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/acs.jmedchem.6b00219","volume":"59","author":"LH Kleijn","year":"2016","unstructured":"Kleijn LH, Oppedijk SF, \u2018t Hart P, Van Harten RM, Martin-Visscher LA, Kemmink J, Breukink E, Martin NI. (2016) Total synthesis of laspartomycin C and characterization of its antibacterial mechanism of action. J Med Chem 59:3569\u20133574","journal-title":"J Med Chem"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/md15050132","volume":"15","author":"Y Mi","year":"2017","unstructured":"Mi Y, Zhang J, He S, Yan X (2017) New peptides isolated from marine cyanobacteria, an overview over the past decade. Mar Drugs 15:132","journal-title":"Mar Drugs"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"11081","DOI":"10.1021\/ja9620301","volume":"118","author":"MT Reese","year":"1996","unstructured":"Reese MT, Gulavita NK, Nakao Y, Hamann MT, Yoshida WY, Coval SJ, Scheuer PJ (1996) Kulolide: a cytotoxic depsipeptide from a cephalaspidean mollusk, Philinopsis speciosa. J Am Chem Soc 118:11081\u201311084","journal-title":"J Am Chem Soc"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/np300321b","volume":"75","author":"PD Boudreau","year":"2012","unstructured":"Boudreau PD, Byrum T, Liu WT, Dorrestein PC, Gerwick WH (2012) Viequeamide A, a cytotoxic member of the kulolide superfamily of cyclic depsipeptides from a marine button cyanobacterium. J Nat Prod 75:1560\u20131570","journal-title":"J Nat Prod"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1021\/np4001027","volume":"76","author":"D Wang","year":"2013","unstructured":"Wang D, Song S, Tian Y, Xu Y, Miao Z, Zhang A (2013) Total synthesis of the marine cyclic depsipeptide viequeamide A. J Nat Prod 76:974\u2013978","journal-title":"J Nat Prod"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1021\/acs.jnatprod.7b00034","volume":"80","author":"J Almaliti","year":"2017","unstructured":"Almaliti J, Malloy KL, Glukhov E, Spadafora C, Guti\u00e9rrez M, Gerwick WH (2017) Dudawalamides A\u2013D, Antiparasitic Cyclic Depsipeptides from the Marine Cyanobacterium Moorea producens. J Nat Prod 80:1827\u20131836","journal-title":"J Nat Prod"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2174\/1568026614666140423105730","volume":"14","author":"X Just-Baringo","year":"2014","unstructured":"Just-Baringo X, Albericio F, \u00c1lvarez M (2014) Chiral thiazoline and thiazole building blocks for the synthesis of peptide-derived natural products. Curr Top Med Chem 14:1244\u20131256","journal-title":"Curr Top Med Chem"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1021\/ol3027347","volume":"14","author":"DS Nielsen","year":"2012","unstructured":"Nielsen DS, Hoang HN, Lohman RJ, Diness F, Fairlie DP (2012) Total synthesis, structure, and oral absorption of a thiazole cyclic peptide, sanguinamide A. Org Lett 14:5720\u20135723","journal-title":"Org Lett"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1021\/acs.jmedchem.5b00919","volume":"58","author":"AT Bockus","year":"2015","unstructured":"Bockus AT, Schwochert JA, Pye CR, Townsend CE, Sok V, Bednarek MA, Lokey RS (2015) Going out on a limb: delineating the effects of \u03b2-branching, N-methylation, and side chain size on the passive permeability, solubility, and flexibility of Sanguinamide A analogues. J Med Chem 58:7409\u20137418","journal-title":"J Med Chem"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1016\/j.bmcl.2012.08.059","volume":"22","author":"PV Desai","year":"2012","unstructured":"Desai PV, Raub TJ, Blanco MJ (2012) How hydrogen bonds impact P-glycoprotein transport and permeability. Bioorg Med Chem Lett 22:6540\u20136548","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature18634","volume":"535","author":"A Zipperer","year":"2016","unstructured":"Zipperer A, Konnerth MC, Laux C, Berscheid A, Janek D, Weidenmaier C, Burian M, Schilling NA, Slavetinsky C, Marschal M, Willmann M (2016) Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535:511\u2013516","journal-title":"Nature"},{"key":"10_CR61","unstructured":"Krismer B, Peschel A, Grond S, Zipperer A, Konnerth MC, Janek D (2016) Patent PCT Int Appl WO 2016151005"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1039\/C7NP00021A","volume":"4","author":"WK Mousa","year":"2017","unstructured":"Mousa WK, Athar B, Merwin NJ, Magarvey NA (2017) Antibiotics and specialized metabolites from the human microbiota. Nat Prod Rep 4:1302\u20131331","journal-title":"Nat Prod Rep"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"874","DOI":"10.7164\/antibiotics.54.874","volume":"54","author":"R Sekizawa","year":"2001","unstructured":"Sekizawa R, Momose I, Kinoshita N, Naganawa H, Hamada M, Muraoka Y, Iinuma H, Takeuchi T (2001) Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp. J Antibiot 54:874\u2013881","journal-title":"J Antibiot"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1021\/acsmedchemlett.6b00100","volume":"7","author":"J Schwochert","year":"2016","unstructured":"Schwochert J, Lao Y, Pye CR, Naylor MR, Desai PV, Gonzalez Valcarcel IC, Barrett JA, Sawada G, Blanco MJ, Lokey RS (2016) Stereochemistry balances cell permeability and solubility in the naturally derived phepropeptin cyclic peptides. ACS Med Chem Lett 7:757\u2013761","journal-title":"ACS Med Chem Lett"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jprot.2018.05.009","volume":"190","author":"H Safavi-Hemami","year":"2018","unstructured":"Safavi-Hemami H, Brogan SE, Olivera BM (2018) Pain therapeutics from cone snail venoms: from Ziconotide to novel non-opioid pathways. J Proteomics 190:12\u201320","journal-title":"J Proteomics"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0196-9781(00)00175-3","volume":"21","author":"R Newcomb","year":"2000","unstructured":"Newcomb R, Abbruscato TJ, Singh T, Nadasdi L, Davis TP, Miljanich G (2000) Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion. Peptides 21:491\u2013501","journal-title":"Peptides"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","volume":"375","author":"A Schmidtko","year":"2010","unstructured":"Schmidtko A, L\u00f6tsch J, Freynhagen R, Geisslinger G (2010) Ziconotide for treatment of severe chronic pain. Lancet 375:1569\u20131577","journal-title":"Lancet"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1073\/pnas.1519960113","volume":"113","author":"K Thell","year":"2016","unstructured":"Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, Kuttke M, Liutkevi\u010di\u016bt\u0117 Z, G\u00f6ransson U, Gr\u00fcndemann C, Schabbauer G (2016) Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 113:3960\u20133965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1021\/ja110166x","volume":"133","author":"VS Aulakh","year":"2011","unstructured":"Aulakh VS, Ciufolini MA (2011) Total synthesis and complete structural assignment of thiocillin I. J Am Chem Soc 133:5900\u20135904","journal-title":"J Am Chem Soc"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/md12010317","volume":"12","author":"X Just-Baringo","year":"2014","unstructured":"Just-Baringo X, Albericio F, \u00c1lvarez M (2014) Thiopeptide antibiotics: retrospective and recent advances. Mar Drugs 12:317\u2013351","journal-title":"Mar Drugs"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1021\/jacs.6b10792","volume":"139","author":"HL Tran","year":"2017","unstructured":"Tran HL, Lexa KW, Julien O, Young TS, Walsh CT, Jacobson MP, Wells JA (2017) Structure\u2013activity relationship and molecular mechanics reveal the importance of ring entropy in the biosynthesis and activity of a natural product. J Am Chem Soc 139:2541\u20132544","journal-title":"J Am Chem Soc"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1021\/ja1016766","volume":"132","author":"N Oku","year":"2010","unstructured":"Oku N, Takada K, Fuller RW, Wilson JA, Peach ML, Pannell LK, McMahon JB, Gustafson KR (2010) Isolation, structural elucidation, and absolute stereochemistry of enigmazole A, a cytotoxic phosphomacrolide from the Papua New Guinea marine sponge Cinachyrella enigmatica. J Am Chem Soc 132:10278\u201310285","journal-title":"J Am Chem Soc"},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1021\/acs.joc.8b00899","volume":"83","author":"Y Ai","year":"2018","unstructured":"Ai Y, Kozytska MV, Zou Y, Khartulyari AS, Maio WA, Smith AB III (2018) Total synthesis of the marine phosphomacrolide, (\u2212)-Enigmazole A, exploiting multicomponent Type I Anion Relay Chemistry (ARC) in conjunction with a late-stage Petasis\u2013Ferrier union\/rearrangement. J Org Chem 83:6110\u20136126","journal-title":"J Org Chem"},{"key":"10_CR74","first-page":"1013","volume":"61","author":"MJ Towle","year":"2001","unstructured":"Towle MJ, Salvato KA, Budrow J, Wels BF, Kuznetsov G, Aalfs KK, Welsh S, Zheng W, Seletsky BM, Palme MH, Habgood GJ (2001) In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res 61:1013\u20131021","journal-title":"Cancer Res"},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1021\/ja00034a086","volume":"114","author":"TD Aicher","year":"1992","unstructured":"Aicher TD, Buszek KR, Fang FG, Forsyth CJ, Jung SH, Kishi Y, Matelich MC, Scola PM, Spero DM, Yoon SK (1992) Total synthesis of halichondrin B and norhalichondrin B. J Am Chem Soc 114:3162\u20133164","journal-title":"J Am Chem Soc"},{"key":"10_CR76","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1016\/j.bmcl.2004.08.069","volume":"14","author":"W Zheng","year":"2004","unstructured":"Zheng W, Seletsky BM, Palme MH, Lydon PJ, Singer LA, Chase CE, Lemelin CA, Shen Y, Davis H, Tremblay L, Towle MJ (2004) Macrocyclic ketone analogues of halichondrin B. Bioorg Med Chem Lett 14:5551\u20135554","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR77","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1200\/JCO.2009.25.8467","volume":"28","author":"J Cortes","year":"2010","unstructured":"Cortes J, Vahdat L, Blum JL, Twelves C, Campone M, Roch\u00e9 H, Bachelot T, Awada A, Paridaens R, Goncalves A, Shuster DE (2010) Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine. J Clin Oncol 28:3922\u20133928","journal-title":"J Clin Oncol"},{"key":"10_CR78","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.bmcl.2017.10.051","volume":"27","author":"JA Camarero","year":"2017","unstructured":"Camarero JA (2017) Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications. Bioorg Med Chem Lett 27:5089\u20135099","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR79","doi-asserted-by":"publisher","first-page":"40493","DOI":"10.1074\/jbc.M112.395442","volume":"287","author":"R Eliasen","year":"2012","unstructured":"Eliasen R, Daly NL, Wulff BS, Andresen TL, Conde-Frieboes KW, Craik DJ (2012) Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J Biol Chem 287:40493\u201340501","journal-title":"J Biol Chem"},{"key":"10_CR80","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1074\/jbc.M109117200","volume":"277","author":"D Tran","year":"2002","unstructured":"Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME (2002) Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem 277:3079\u20133084","journal-title":"J Biol Chem"},{"key":"10_CR81","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJM198312153092406","volume":"309","author":"S Reichlin","year":"1983","unstructured":"Reichlin S (1983) Somatostatin. N Engl J Med 309:1495\u20131501","journal-title":"N Engl J Med"},{"key":"10_CR82","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1126\/science.1158668","volume":"322","author":"ZR Donaldson","year":"2008","unstructured":"Donaldson ZR, Young LJ (2008) Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322:900\u2013904","journal-title":"Science"},{"key":"10_CR83","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1016\/j.bmc.2018.03.019","volume":"26","author":"R Beard","year":"2018","unstructured":"Beard R, Stucki A, Schmitt M, Py G, Grundschober C, Gee AD, Tate EW (2018) Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs. Bioorg Med Chem 26:3039\u20133045","journal-title":"Bioorg Med Chem"},{"key":"10_CR84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cbpa.2018.05.010","volume":"44","author":"V Poongavanam","year":"2018","unstructured":"Poongavanam V, Doak BC, Kihlberg J (2018) Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space. Curr Opin Chem Biol 44:23\u201329","journal-title":"Curr Opin Chem Biol"}],"container-title":["Methods in Molecular Biology","Cyclic Peptide Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9504-2_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T10:09:10Z","timestamp":1558951750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9504-2_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493995035","9781493995042"],"references-count":84,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9504-2_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"28 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}